BIODESIX, INC. - Common Stock, $0.001 par value per share (BDSX)

CUSIP: 09075X108

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
+11,280,790
Put/Call ratio
378%
SEC-reported price per share
$2.30
Number of holders
31
Value change
+$25,970,147
Number of buys
18
Open additional details 1 more signal available
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,515,087

Security key

09075X108

Report period

Q4 2022

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of BDSX - BIODESIX, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Birchview Capital, LP
Disclosed value leader
Birchview Capital, LP
Comparable rows
0/15
Latest evidence
21 Nov 2022
13F 3/4/5 Highest disclosed value: $3,010,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Birchview Capital, LP has the largest disclosed position value at $3.01M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Birchview Capital, LP's linked filing trail.
Disclosed position value Top 5
Birchview Capital, LP $3.01M
WELLS FARGO & COMPANY/MN $984K
ESSEX INVESTMENT MANAGEMENT CO LLC $480K
VANGUARD GROUP INC $305K
Cannell & Co. $261K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Birchview Capital, LP
13F
Company
13F
—
denominator unverified
$3,010,000
2,370,071 shares
— 30 Sep 2022
WELLS FARGO & COMPANY/MN
13F
Company
13F
—
denominator unverified
$984,000
768,725 shares
— 30 Sep 2022
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
13F
—
denominator unverified
$480,000
378,023 shares
— 30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$305,000
239,656 shares
— 30 Sep 2022
Cannell & Co.
13F
Company
13F
—
denominator unverified
$261,000
205,605 shares
— 30 Sep 2022
Endurant Capital Management LP
13F
Company
13F
—
denominator unverified
$165,000
130,136 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
16,040,137
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q4 2022 holders
31
Holder diff
30
Investor Q1 2026 Shares Q4 2022 Shares Share Diff Share Chg % Q1 2026 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .